Loading the section
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
CG Oncology, Inc. trades on Nasdaq under the ticker CGON. The company belongs to the Health care sector. The trading history on this page starts on 25 January 2024.
Over the past 52 weeks CGON has traded between 35.80 $ and 80.97 $. As of 09 October 2026 the price stood 60.79 % of the way from the 52-week low to the high.
Over one year CGON shares rose 66.47 %; over six months they fell 7.73 %. Volatility over 90 days is 49.99 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1,098, above the sector median of 3.9. Price to book is 5.1, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 61.65 | 63.71 | 61.11 | 63.26 | 910,300 |
| 07 October 2026 | 62.68 | 63.64 | 61.90 | 62.38 | 621,800 |
| 06 October 2026 | 69.17 | 69.17 | 63.19 | 63.64 | 774,400 |
| 05 October 2026 | 67.60 | 68.95 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
CG Oncology, Inc. (CGON) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, net income was -161.0m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:400 SPECTRUM CENTER DRIVE SUITE 2040, IRVINE, CA, 92618, US
CGON has a return on equity of −17.10 %, above the sector median of −41.68 %. Return on assets is −16.45 %, above the sector median of −32.11 %.
| 428M |
| RVMDRevolution Medicines, Inc. | 189.76 | +0.87 % | 409M |
| HALOHalozyme Therapeutics, Inc. | 111.70 | +1.69 % | 251M |
| BIIBBiogen Inc. | 226.01 | +3.47 % | 224M |
| TECHBio-Techne Corp | 72.46 | +0.01 % | 215M |
| 65.71 |
| 68.71 |
| 788,400 |
| 02 October 2026 | 69.35 | 69.73 | 66.61 | 67.38 | 2M |
| 01 October 2026 | 70.38 | 71.27 | 68.32 | 68.35 | 984,900 |
| 30 September 2026 | 70.34 | 73.16 | 69.23 | 70.89 | 1M |
| 29 September 2026 | 69.56 | 70.68 | 68.26 | 70.52 | 1M |
| 28 September 2026 | 66.96 | 69.94 | 66.01 | 69.61 | 2M |
| 25 September 2026 | 69.32 | 70.05 | 66.76 | 67.15 | 1M |
| 24 September 2026 | 73.10 | 73.44 | 68.15 | 68.76 | 1M |
| 23 September 2026 | 76.87 | 77.79 | 71.86 | 73.36 | 830,900 |
| 22 September 2026 | 78.31 | 80.63 | 76.25 | 77.74 | 2M |
| 21 September 2026 | 75.74 | 78.47 | 74.22 | 78.25 | 1M |
| 18 September 2026 | 75.87 | 75.87 | 72.82 | 74.62 | 2M |
| 17 September 2026 | 75.00 | 76.50 | 74.43 | 75.62 | 894,300 |
| 16 September 2026 | 72.66 | 74.59 | 72.66 | 74.12 | 795,600 |
| 15 September 2026 | 74.13 | 74.13 | 72.48 | 72.55 | 1M |
| 14 September 2026 | 72.30 | 74.67 | 71.78 | 73.79 | 829,900 |
| 11 September 2026 | 72.82 | 75.00 | 71.53 | 72.35 | 759,800 |